SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form DEF 14A - Other definitive proxy statements:
SEC Accession No. 0001683168-23-007244
Filing Date
2023-10-18
Accepted
2023-10-18 13:32:33
Documents
3
Period of Report
2023-12-07

Document Format Files

Seq Description Document Type Size
1 DEFINITIVE PROXY STATEMENT sunshine_def14a.htm DEF 14A 405182
2 GRAPHIC image_003.jpg GRAPHIC 90925
3 GRAPHIC image_004.jpg GRAPHIC 83369
  Complete submission text file 0001683168-23-007244.txt   646728
Mailing Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5
Business Address 6500 TRANS-CANADA HIGHWAY 4TH FLOOR POINTE-CLAIRE A8 H9R 0A5 514-426-6161
Sunshine Biopharma, Inc (Filer) CIK: 0001402328 (see all company filings)

IRS No.: 205566275 | State of Incorp.: CO | Fiscal Year End: 1231
Type: DEF 14A | Act: 34 | File No.: 001-41282 | Film No.: 231331822
SIC: 2834 Pharmaceutical Preparations